Clinical Trials Directory

Trials / Completed

CompletedNCT02319993

Traditional Chinese Medicine Suan Tsao Jen Tang and Tian-Wang-Bu-Xin Dan in Patients With Primary Insomnia.

Traditional Chinese Medicine Suan Tsao Jen Tang and Tian-Wang-Bu-Xin Dan in Patients With Primary Insomnia. A Multi-center Clinical Trial

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
128 (actual)
Sponsor
Chung Shan Medical University · Academic / Other
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Not accepted

Summary

keywords: Traditional Chinese Medicine, Herbs, Clinical trial, Insomnia, Quality of life, Suan-Zao-Ren Tang, Tian-wang-bu-xin-dan

Detailed description

Title: Traditional Chinese Medicine Suan Tsao Jen Tang and Tian-Wang-Bu-Xin Dan in patients with primary insomnia. A multi-center, double blind, placebo controlled clinical trial. (First year of two-years' project) Design: Randomized, placebo-controlled trial comprising 3 arms: SZRT, placebo, TWBXD. Setting: The Chung Shan Medical University Affiliated Hospital and the Taipei City Hospital. Methods: A total of 128 subjects 20-80 years of age with a history of insomnia at least 1 month were recruited randomly assigned to SZRT (n = 48), placebo (n =32), TWBXD (n =48) and were instructed to take 6 gm 2 times per day of SZRT, TWBXD or placebo for a period of 4 weeks. The primary outcome measures were the mean component scores of the Pittsburgh Sleep Quality Index (PSQI). Secondary outcome parameter were the global score on the World Health Organization Quality of Life questionnaire - Taiwan brief version, drugs consumption counts, sleep diary and safety profiles by structures questionnaires.

Conditions

Interventions

TypeNameDescription
DRUGTIAN WANG BU XIN DANassigned to TWBXD (n =48) and were instructed to take 6 gm 2 times per day of TWBXD for a period of 4 weeks.
DRUGSuan Tzao Ren Tangassigned to SZRT (n = 48) and were instructed to take 6 gm 2 times per day of SZRT for a period of 4 weeks.
DRUGPlacebo1/10 TIAN WANG BU XIN DAN assigned to placebo (n =32) and were instructed to take 6 gm 2 times per day of placebo for a period of 4 weeks.

Timeline

Start date
2013-05-01
Primary completion
2014-10-01
Completion
2014-10-01
First posted
2014-12-19
Last updated
2016-01-20

Source: ClinicalTrials.gov record NCT02319993. Inclusion in this directory is not an endorsement.